Telemedicine for Depression in Primary Care
The Efficacy of Telemedicine for Improving Depression Outcomes in Primary Care
1 other identifier
interventional
120
1 country
4
Brief Summary
Background: In Italy, several recent studies found that a large percentage of patients attending Primary Care (PC) clinics meet criteria for at least one common mental disorder, as they show high rates of depression, anxiety, and co-morbid anxiety and depression. These patients may experience significant functional impairment and suffer from unexplained somatic symptoms, and often remain undetected and untreated. Consistent evidence for the effectiveness of organized care programs for depression, by improving quality of care and treatment adherence, is now available. Fundamental elements of these programs include algorithms to prompt the proper and timely implementation of evidence-based treatments, structured outcome assessment and systematic outreach. Telemedicine tools may represent a valuable strategy for improving depression outcomes in PC. Aims: 1.To develop and employ computer-based assessment to more accurately and timely detect patient depression in PC settings; 2.To evaluate the feasibility and effectiveness of a care support program developed in conjunction with the PC-based assessment for patients suffering from depression, as based on two main objectives: 2a.To support GP decisions with treatment algorithms and improve the quality of GP and mental health service collaboration; 2b.To improve patient compliance and treatment adherence by using appropriate telecommunication tools and technologically advanced tools to conduct systematic routine assessment. Although much of this system will be computer-based, live telephonic and in-person contacts will also be included as needed. Study Design: The study is a randomized controlled trial, involving four PC group clinics (GCs) located in two areas of Northern Italy. Two PC clinics will use the experimental protocol; the other two will serve as controls. The study will compare two different conditions:
- Group 1 (experimental): GPs will use a Computer Decision Support System with treatment algorithms and advice and supervision from a consultant psychiatrist. Patients will receive reminders via mobile texting or automatic mobile (or landline) phone calls to improve adherence to the treatment prescribed.
- Group 2 (control): GPs will provide TAU, will make their own decisions and will therefore not use the CDSS. Patients will not receive any reminders. All enrolled patients will be administered and will fill in the IDS-SR at baseline, 3 and 6-months: the IDS-SR score will be used as a primary endpoint.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Nov 2012
Typical duration for not_applicable depression
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2012
CompletedFirst Posted
Study publicly available on registry
October 5, 2012
CompletedStudy Start
First participant enrolled
November 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedFebruary 24, 2016
February 1, 2016
3.2 years
October 3, 2012
February 23, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients reaching remission
The primary end-point will be the proportion of patients reaching remission by 6 months, as represented by an exit IDS-SR score of \<or=12.
6 months
Secondary Outcomes (1)
Number of GP appointments actually attended during follow-up
6 months
Study Arms (2)
Computerized Decision Support System (CDSS)
EXPERIMENTALGPs will use a CDSS with treatment algorithms, supervision from a consultant psychiatrist, and despatch to patients of reminders via mobile texting or automatic mobile (or landline) phone calls to improve adherence to the treatment prescribed.
Treatment as usual
NO INTERVENTIONGPs will provide TAU, will make their own decisions and will therefore not use the CDSS. Patients will not receive any reminders.
Interventions
Eligibility Criteria
You may qualify if:
- Patients aged 18-65 years
- PHQ-9 score of \>or=14 at baseline
- IDS-SR score of \>or=26 at baseline
- No filling of antidepressant medication prescription for 270 prior days
- Illiteracy or the lack of working telephone to receive reminders.
You may not qualify if:
- Current diagnosis of alcohol or substance dependence
- History of Bipolar Disorder determined by a baseline Composite International Diagnostic Interview (CIDI) screening scale of lifetime mania/hypomania
- Any current prescription for mood stabilizer or antipsychotic medication
- Female with positive pregnancy test
- General medical conditions which contraindicate antidepressant medications
- Clinical status requiring inpatient or day hospital treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Health Telematic Network srl
Brescia, Brescia, 25125, Italy
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Brescia, Brescia, 25125, Italy
Dipartimento di Scienze Mediche Sperimentali e Cliniche, Università di Udine
Udine, Udine, 33100, Italy
Marco B. Rocchi
Urbino, Italy
Related Publications (1)
Balestrieri M, Sisti D, Rocchi M, Rucci P, Simon G, Araya R, de Girolamo G. Effectiveness of clinical decision support systems and telemedicine on outcomes of depression: a cluster randomized trial in general practice. Fam Pract. 2020 Nov 28;37(6):731-737. doi: 10.1093/fampra/cmaa077.
PMID: 32766705DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matteo Balestrieri, M.D.
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Scientific Director
Study Record Dates
First Submitted
October 3, 2012
First Posted
October 5, 2012
Study Start
November 1, 2012
Primary Completion
January 1, 2016
Study Completion
May 1, 2016
Last Updated
February 24, 2016
Record last verified: 2016-02